Mutations in ATP13A2 (PARK9), encoding a lysosomal P-type ATPase, are associated with both Kufor–Rakeb syndrome (KRS) and neuronal ceroid lipofuscinosis. Here, ATP13A2 is linked to parkinsonism due to ATP13A2 deficiency.